Peer-reviewedCC BY-NC 4.0Childhood Kidney Diseases
Comment on “Biomarkers for the early diagnosis of Alport syndrome and associated kidney damage”
- 1Department of Hospital Pediatrics, Andijan State Medical Institute, Andijan, Uzbekistan
- 2Department of Anaesthesiology-Reanimatology and Emergency Medicine, Andijan State Medical Institute, Andijan, Uzbekistan
- 3Department of Childhood Diseases in Family Medicine, Tashkent State Medical University, Tashkent, Uzbekistan
Related
- Urinary Peptidomic Signature for Noninvasive Diagnosis of Alport Syndrome in Children.
- A Case of Autosomal Dominant Alport Syndrome with Normal Type IV Collagen α5 Staining Diagnosed by a Genetic Analysis
- Biomarkers for the diagnosis and management of cardiovascular-kidney-metabolic syndrome: recent advances and prospects for clinical application
- Biomarkers for differential diagnosis of myocarditis, acute coronary syndrome, and sepsis-induced cardiomyopathy
- Anesthetic challenges in a child with Alport syndrome undergoing prone surgery with a laryngeal mask airway: a case report
BibTeX
@article{boltaboeva2026comment,
title = {{Comment on “Biomarkers for the early diagnosis of Alport syndrome and associated kidney damage”}},
author = {Muqaddas Boltaboeva and Abdulhamid Haydarov and Lola Rakhmanova},
journal = {Childhood Kidney Diseases},
year = {2026},
month = oct,
doi = {10.3339/ckd.26.033},
url = {https://doi.org/10.3339/ckd.26.033},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Comment on “Biomarkers for the early diagnosis of Alport syndrome and associated kidney damage”
AU - Muqaddas Boltaboeva
AU - Abdulhamid Haydarov
AU - Lola Rakhmanova
PY - 2026
DA - 2026/10/30
JO - Childhood Kidney Diseases
DO - 10.3339/ckd.26.033
UR - https://doi.org/10.3339/ckd.26.033
SN - 2384-0242
SN - 2384-0250
ER -